Reproductive health as a sentinel of chronic disease in women

Women's Health

Volumn 5, Issue 2, 2009, Pages 101-105

  Rich Edwards, Janet W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; INSULIN; SEX HORMONE BINDING GLOBULIN;

ANGIOGENESIS; ANOVULATION; BREAST CANCER; CANCER RISK; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHROMOSOME ABERRATION; EDITORIAL; FEMALE; FEMALE INFERTILITY; GLUCOSE INTOLERANCE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTRAUTERINE GROWTH RETARDATION; ISCHEMIC HEART DISEASE; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MENSTRUATION; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; POSTMENOPAUSE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; REPRODUCTIVE HEALTH; RISK ASSESSMENT; SPONTANEOUS ABORTION; THROMBOSIS; VASCULAR DISEASE; WOMEN'S HEALTH; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; PREGNANCY; REPRODUCTION; RISK FACTOR;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; FEMALE; HUMANS; MENSTRUAL CYCLE; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS; REPRODUCTIVE MEDICINE; RISK FACTORS; WOMEN'S HEALTH;

EID: 67650130445     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.5.2.101     Document Type: Editorial

References (57)

1. Good JM: The Study of Medicine (2nd Edition). Baldwin, Craddock and Joy, London, UK, 5, 203 (1825).
2. Gail MH, Brinton LA, Byar DP et al.: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J. Natl Cancer Inst. 81, 1879-1886 (1989).
3. Butler LM, Potischman NA, Newman B et al.: Menstrual risk factors and early-onset breast cancer. Cancer Causes Control 11, 451-458 (2000).
4. Terry KL, Willett WC, Rich-Edwards JW, Hunter DJ, Michels KB: Menstrual cycle characteristics and incidence of premenopausal breast cancer. Cancer Epidemiol. Biomarkers Prev. 14, 1509-1513 (2005).
5. Solomon CG, Hu FB, Dunaif A et al.: Menstrual cycle irregularity and risk for future cardiovascular disease. J. Clin. Endocrinol. Metab. 87, 2013-2017 (2002).
6. De Kleijn MJ, Van der Schouw YT, Van der Graaf Y: Reproductive history and cardiovascular disease risk in postmenopausal women: a review of the literature. Maturitas 33, 7-36 (1999).
7. Bertuccio P, Tavani A, Gallus S, Negri E, La Vecchia C: Menstrual and reproductive factors and risk of non-fatal acute myocardial infarction in Italy. Eur. J. Obstet. Gynecol. Reprod. Biol. 134, 67-72 (2007).
8. Wild S, Pierpoint T, McKeigue P, Jacobs H: Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin. Endocrinol. (Oxf.) 52, 595-600 (2000).
9. Amowitz LL, Sobel BE: Cardiovascular consequences of polycystic ovary syndrome. Endocrinol. Metab. Clin. North Am. 28, 439-458 (1999).
10. Shaw LJ, Bairey Merz CN, Azziz R et al.: Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institute of Health - National Heart, Lung, and Blood Institute sponsored women's ischemia syndrome evaluation. J. Clin. Endocrinol. Metab. 93, 1276-1284 (2008).
11. Legro RS, Kunselman AR, Dodson WC, Dunaif A: Prevalence and predictors of risk of Type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab. 84, 165-169 (1999).
12. Kousta E, Tolis G, Franks S: Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences. Hormones (Athens) 4, 133-147 (2005).
13. Legro RS: Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocrine Rev. 24, 302-312 (2003).
14. Rizzo M, Berneis K, Spinas G, Rini GB, Carmina E: Long-term consequences of polycystic ovary syndrome on cardiovascular risk. Fertil. Steril. DOI: 10.1016/j.fertnstert.2008.09.070 (2008) (Epub ahead of print).
15. Kaaks R: Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7, 605-625 (1996).
16. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS: Mortality of women with polycystic ovary syndrome at long-term follow-up. J. Clin. Epidemiol. 51, 581-586 (1998).
17. Balen A: Polycystic ovary syndrome and cancer. Hum. Reprod. Update 7, 522-525 (2001).
18. Brinton LA, Westhoff CL, Scoccia B et al.: Causes of infertility as predictors of subsequent cancer risk. Epidemiology 16, 500-507 (2005).
19. Somigliana E, Vigano P, Parazzini F, Stoppelli S, Giambattista E, Vercellini P: Association between endometriosis and cancer: a comprehensive review and a critical ana lysis of clinical and epidemiological evidence. Gynecol. Oncol. 101, 331-341 (2006).
20. Ness RB: Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am. J. Obstet. Gynecol. 189, 280-294 (2003).
21. Ness RB, Modugno F: Endometriosis as a model for inflammation-hormone interactions in ovarian and breast cancers. Eur. J. Cancer 42, 691-703(2006).
22. Whitcomb BW, Schisterman EF, Klebanoff MA et al.: Circulating chemokine levels and miscarriage. Am. J. Epidemiol. 166, 323-331 (2007).
23. Garcia-Enguidanos A, Calle ME, Valero J, Luna S, Dominguez-Rojas V: Risk factors in miscarriage: a review. Eur. J. Obstet. Gynecol. Reprod. Biol. 102, 111-119 (2002).
24. Beral V, Bull D, Doll R, Peto R, Reeves G; Collaborative group on hormonal factors in breast cancer: breast cancer and abortion: collaborative reana lysis of data from 53 epidemiological studies, including 83000 women with breast cancer from 16 countries. Lancet 363, 1007-1016 (2004).
25. Sattar N, Greer IA: Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? Br. Med. J. 325, 157-160 (2002).
26. Metzger BE, Cho NH, Roston SM, Radvany R: Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 16, 1598-1605 (1993).
27. Shah BR, Retnakaran R, Booth GL: Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care 31, 1668-1669 (2008).
28. Lawlor DA, Smith GD, Ebrahim S: Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study. Cancer Causes Control 15, 267-275 (2004).
29. Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B: Diabetes mellitus and breast cancer. Lancet Oncol. 6, 103-111 (2005).
30. Perrin MC, Terry MB, Kleinhaus K et al.: Gestational diabetes and the risk of breat cancer among women in the Jerusalem Perinatal Study. Breast Cancer Res. Treat. 108, 129-135 (2008).
31. Rollison DE, Giuliano AR, Sellers TA et al.: Population based case control study of diabetes and breat cancer risk in Hispanic and non-Hispanic White women living in the southwestern states. Am. J. Epidemiol. 167, 447-456 (2008).
32. Troisi R, Weiss HA, Hoover RN et al.: Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 9, 641-647 (1998).
33. Thadhani R, Solomon CG: Preeclampsia - a glimpse into the future? N. Engl. J. Med. 359, 858-860 (2008).
34. Bellamy L, Casas JP, Hingorani AD, Williams DJ: Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. Br. Med. J. 335, 974 (2007).
35. Skjaerven R, Wilcox AJ, Melve KK, Irgens LM, Vatten LJ, Lie RT: Preeclampsia and long-term maternal mortality. Am. J. Epidemiol. 165, S27 (2007).
36. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM: Preeclampsia and the risk of end-stage renal disease. N. Engl. J. Med. 359, 800-809 (2008).
37. Funai EF, Friedlander Y, Paltiel O et al.: Long-term mortality after pre-eclampsia. Epidemiology 16, 206-215 (2005).
38. Magnussen EB, Vatten LJ, Lund-Nilsen TI, Salvesen KA, Davey Smith G, Romundstad PR: Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. Br. Med. J. 335, 978-981 (2007).
39. Davey-Smith G, Hypponen E, Power C, Lawlor DA: Offspring birth weight and parental mortality: prospective observational study and meta-ana lysis. Am. J. Epidemiol. 166, 160-169 (2007).
40. Davey-Smith G, Hart C, Ferrell C et al.: Birth weight of offspring and mortality in the Renfrew and Paisley study: prospective observational study. Br. Med. J. 315, 1189-1193 (1997).
41. Davey-Smith G, Whitley E, Gissler M, Hemminki E: Birth dimensions of offspring, premature birth, and the mortality of mothers. Lancet 356, 2066-2067 (2000).
42. Davey-Smith G, Harding S, Rosato M: Relation between infants' birth weight and mothers' mortality: prospective observational study. Br. Med. J. 320, 839-840 (2000).
43. Catov J, Newman A, Roberts J et al.: Association between infant birth weight and maternal cardiovascular risk factors in the Health, Aging, and Body Composition Study. Ann. Epidemiol. 17, 36-43 (2007).
44. Wohlfahrt J, Melbye M: Maternal risk of breast cancer and birth characteristics of offspring by time since birth. Epidemiology 10, 441-444 (1999).
45. Cnattingius S, Torrang A, Ekbom A, Granath F, Petersson G, Lambe J: Pregnancy characteristics and maternal risk of breast cancer. JAMA 294, 2474-2480 (2005).
46. Cohn BA, Cirillo PM, Christianson RE, van de Berg BJ, Siiteri PK: Placental characteristics and reduced risk of maternal breast cancer. J. Natl Cancer Inst. 93, 1133-1140 (2001).
47. Goldenberg RL, Culhane JF, Iams JD, Romero R: Epidemiology and causes of preterm birth. Lancet 371, 75-84 (2008).
48. Irgens HU, Reisaeter L, Irgens LM, Lie RT: Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br. Med. J. 323, 1213-1217 (2001).
49. Smith GD, Sterne J, Tynelius P, Lawlor DA, Rasmussen F: Birth weight of offspring and subsequent cardiovascular mortality of the parents. Epidemiology 16, 563-569 (2005).
50. Smith G, Whitley E, Gissler E, Hemminki E: Birth dimensions of offspring, premature birth, and the mortality of mothers. Lancet 356, 2066-2067 (2000).
51. Smith GD, Pell JP, Walsh D: Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births. Lancet 357, 2002 (2001).
52. Polednak, Janerich AD: Characteristics of first pregnancy in relation to early breast cancer: a case-control study. J. Reprod. Med. 28, 314-318 (1983).
53. Innes KE, Byers TE: First pregnancy characteristics and subsequent breast cancer risk among young women. Int. J. Cancer 112, 306-311 (2004).
54. Melbye M, Wohlfahrt J, Andersen AM, Westergaard T, Andersen PK: Pretem delivery and risk of breast cancer. Br. J. Cancer 80, 609-613 (1999).
55. Vatten LJ, Romundstad PR, Trichopoulos D, Skjaerven R: Pre-eclampsia in pregnancy and subsequent risk for breast cancer. Br. J. Cancer 87, 971-973 (2002).
56. Hsieh, Cc, Lambe M, Trichopoulos D, Adami HO, Ekbom A: Delivery of premature newborns and maternal breast-cancer risk. Lancet 353, 1239 (1999).
57. Mucci LA, Dickman PW, Lambe M et al.: Gestational age and fetal growth in relation to maternal ovarian cancer risk in a Swedish cohort. Cancer Epidemiol. Biomarkers Prev. 16, 1828-1832 (2007).